HOME > About Us > RIBOMIC USA Inc.

RIBOMIC, Inc. is a leading company in the world developing innovative aptamer therapeutics.


Yusuf AliRIBOMIC USA Inc. was established in August 2017 for the purpose of clinical development of drugs using RNA aptamers created by RIBOMIC Inc. and business development activities involving to license RIBOMIC drugs to other pharmaceutical companies and performing new joint research programs.

CEO Yusuf Ali

Company Name RIBOMIC USA Inc.
Address 2120 University Ave Berkeley CA 94704 USA
Date Establishment August 8,2017
CEO Yusuf Ali
Web http://www.ribomic.com/
Inquiries We accept inquiry by e-mail.
Please send e-mail from this web site.